Morphic Therapeutic
Biotechnology company developing a new generation of oral integrin therapies. Learn more
Launch date
Employees
Market cap
$2.9b
Enterprise valuation
$2.2b (Public information from Aug 2024)
Share price
$56.99 MORF
Waltham Massachusetts (HQ)
Authorizing premium user...